Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Reiffel, JA
   Issues in the use of generic antiarrhythmic drugs
   CURRENT OPINION IN CARDIOLOGY
   
   J.A. Reiffel, "Issues in the use of generic antiarrhythmic drugs", CURR OPIN C, 16(1), 2001, pp. 23-29
2. Page, RL; Reiffel, JA; Tavel, ME
   Asymptomatic atrial fibrillation - Problems of management
   CHEST
   
   R.L. Page et al., "Asymptomatic atrial fibrillation - Problems of management", CHEST, 119(2), 2001, pp. 628-631
3. Reiffel, JA
   Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues
   CURRENT OPINION IN CARDIOLOGY
   
   J.A. Reiffel, "Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues", CURR OPIN C, 15(1), 2000, pp. 7-11
4. Reiffel, JA; Kowey, PR
   Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias
   AMERICAN JOURNAL OF CARDIOLOGY
   
   J.A. Reiffel e P.R. Kowey, "Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias", AM J CARD, 85(9), 2000, pp. 1151
5. Reiffel, JA
   Drug choices in the treatment of atrial fibrillation
   AMERICAN JOURNAL OF CARDIOLOGY
   
   J.A. Reiffel, "Drug choices in the treatment of atrial fibrillation", AM J CARD, 85(10A), 2000, pp. 12D-19D
6. Reiffel, JA
   Formulation substitution and other pharmacokinetic variability: Underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice
   AMERICAN JOURNAL OF CARDIOLOGY
   
   J.A. Reiffel, "Formulation substitution and other pharmacokinetic variability: Underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice", AM J CARD, 85(10A), 2000, pp. 46D-52D
7. Exner, DV; Reiffel, JA; Epstein, AE; Ledingham, R; Reiter, MJ; Yao, Q; Duff, HJ; Follmann, D; Schron, E; Greene, HL; Carlson, MD; Brodsky, MA; Akiyama, T; Baessler, C; Anderson, JL
   Beta-blocker use and survival in patients with ventricular fibrillation orsymptomatic ventricular tachycardia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   D.V. Exner et al., "Beta-blocker use and survival in patients with ventricular fibrillation orsymptomatic ventricular tachycardia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial", J AM COL C, 34(2), 1999, pp. 325-333
8. Reiffel, JA
   Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias
   AMERICAN HEART JOURNAL
   
   J.A. Reiffel, "Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias", AM HEART J, 137(2), 1999, pp. 372-373
9. KASSOTIS J; COSTEAS C; BLITZER M; REIFFEL JA
   RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 3
   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
   
   J. Kassotis et al., "RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 3", PACE, 21(5), 1998, pp. 1133-1145
10. COSTEAS C; KASSOTIS J; BLITZER M; REIFFEL JA
    RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 2
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    C. Costeas et al., "RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 2", PACE, 21(4), 1998, pp. 742-752
11. BLITZER M; COSTEAS C; KASSOTIS J; REIFFEL JA
    RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 1
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    M. Blitzer et al., "RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 1", PACE, 21(3), 1998, pp. 590-602
12. EXNER DV; EPSTEIN AE; REITER MJ; YAO Q; LEDINGHAM R; REIFFEL JA; BRODSKY M; AKIYAMA T; SCHRON E; FOLLMANN D; ANDERSON J
    BETA-BLOCKER USE AND MORTALITY IN THE ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) COHORT
    Circulation
    
    D.V. Exner et al., "BETA-BLOCKER USE AND MORTALITY IN THE ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) COHORT", Circulation, 98(17), 1998, pp. 2598-2598
13. REITER MJ; REIFFEL JA
    IMPORTANCE OF BETA-BLOCKADE IN THE THERAPY OF SERIOUS VENTRICULAR ARRHYTHMIAS
    The American journal of cardiology
    
    M.J. Reiter e J.A. Reiffel, "IMPORTANCE OF BETA-BLOCKADE IN THE THERAPY OF SERIOUS VENTRICULAR ARRHYTHMIAS", The American journal of cardiology, 82(4A), 1998, pp. 9-19
14. REIFFEL JA; REITER MJ; BLITZER M
    ANTIARRHYTHMIC DRUGS AND DEVICES FOR THE MANAGEMENT OF VENTRICULAR TACHYARRHYTHMIA IN ISCHEMIC-HEART-DISEASE
    The American journal of cardiology
    
    J.A. Reiffel et al., "ANTIARRHYTHMIC DRUGS AND DEVICES FOR THE MANAGEMENT OF VENTRICULAR TACHYARRHYTHMIA IN ISCHEMIC-HEART-DISEASE", The American journal of cardiology, 82(4A), 1998, pp. 31-40
15. REIFFEL JA; CAMM J
    A SYMPOSIUM - ATRIAL-FIBRILLATION - MECHANISM AND MANAGEMENT - INTRODUCTION
    The American journal of cardiology
    
    J.A. Reiffel e J. Camm, "A SYMPOSIUM - ATRIAL-FIBRILLATION - MECHANISM AND MANAGEMENT - INTRODUCTION", The American journal of cardiology, 82, 1998, pp. 1-1
16. PRITCHETT E; KANNEL WB; REIFFEL JA; OLSHANSKY B; LUDERITZ B; REITER M; FALK RH; CAMM J
    EPIDEMIOLOGY AND INCIDENCE OF ATRIAL-FIBRILLATION - DISCUSSION
    The American journal of cardiology
    
    E. Pritchett et al., "EPIDEMIOLOGY AND INCIDENCE OF ATRIAL-FIBRILLATION - DISCUSSION", The American journal of cardiology, 82, 1998, pp. 8-9
17. SUNG R; FALK RH; CAMM J; REIFFEL JA; KERR CR; WALDO A; WHARTON M; KAUFMAN E
    ATRIAL-FIBRILLATION - ETIOLOGY, HISTOLOGY AND RISK-FACTORS - DISCUSSION
    The American journal of cardiology
    
    R. Sung et al., "ATRIAL-FIBRILLATION - ETIOLOGY, HISTOLOGY AND RISK-FACTORS - DISCUSSION", The American journal of cardiology, 82, 1998, pp. 16-17
18. WALDO A; NADEMANEE K; KOWEY PR; REIFFEL JA; FALK RH
    ANTICOAGULATION IN ATRIAL-FIBRILLATION PATIENTS - DISCUSSION
    The American journal of cardiology
    
    A. Waldo et al., "ANTICOAGULATION IN ATRIAL-FIBRILLATION PATIENTS - DISCUSSION", The American journal of cardiology, 82, 1998, pp. 41-42
19. SUNG R; GRANT AO; FELD G; REITER M; FRIEDMAN PL; REIFFEL JA; KERR CR; CAMM J
    ELECTROPHYSIOLOGY OF ANTIARRHYTHMIC DRUGS FOR ATRIAL-FIBRILLATION - DISCUSSION
    The American journal of cardiology
    
    R. Sung et al., "ELECTROPHYSIOLOGY OF ANTIARRHYTHMIC DRUGS FOR ATRIAL-FIBRILLATION - DISCUSSION", The American journal of cardiology, 82, 1998, pp. 48-49
20. REIFFEL JA; REIMOLD SC
    METAANALYSIS OF THE EFFICACY OF PROPAFENONE FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS - DISCUSSION
    The American journal of cardiology
    
    J.A. Reiffel e S.C. Reimold, "METAANALYSIS OF THE EFFICACY OF PROPAFENONE FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS - DISCUSSION", The American journal of cardiology, 82, 1998, pp. 71-71
21. REIFFEL JA
    SELECTING AN ANTIARRHYTHMIC AGENT FOR ATRIAL-FIBRILLATION SHOULD BE APATIENT-SPECIFIC, DATA-DRIVEN DECISION
    The American journal of cardiology
    
    J.A. Reiffel, "SELECTING AN ANTIARRHYTHMIC AGENT FOR ATRIAL-FIBRILLATION SHOULD BE APATIENT-SPECIFIC, DATA-DRIVEN DECISION", The American journal of cardiology, 82, 1998, pp. 72-80
22. GRANT AO; REIFFEL JA; WINTERS S; PAGE R; WEBB C; KUTALEK S; NADEMANEE K; OLSHANSKY B; CARLSON M; FERRICK K
    DATA-DRIVEN DECISIONS - PICKING THE CORRECT AGENT - DISCUSSION
    The American journal of cardiology
    
    A.O. Grant et al., "DATA-DRIVEN DECISIONS - PICKING THE CORRECT AGENT - DISCUSSION", The American journal of cardiology, 82, 1998, pp. 80-81
23. REIFFEL JA
    IMPACT OF STRUCTURAL HEART-DISEASE ON THE SELECTION OF CLASS-III ANTIARRHYTHMICS FOR THE PREVENTION OF ATRIAL-FIBRILLATION AND FLUTTER
    The American heart journal
    
    J.A. Reiffel, "IMPACT OF STRUCTURAL HEART-DISEASE ON THE SELECTION OF CLASS-III ANTIARRHYTHMICS FOR THE PREVENTION OF ATRIAL-FIBRILLATION AND FLUTTER", The American heart journal, 135(4), 1998, pp. 551-556
24. REIFFEL JA; HAHN E; HARTZ V
    IS PROCAINAMIDE FAILURE AT ELECTROPHYSIOLOGIC TESTING REALLY AN APPROPRIATE MARKER FOR DRUG-RESISTANT VENTRICULAR TACHYARRHYTHMIAS
    Journal of the American College of Cardiology
    
    J.A. Reiffel et al., "IS PROCAINAMIDE FAILURE AT ELECTROPHYSIOLOGIC TESTING REALLY AN APPROPRIATE MARKER FOR DRUG-RESISTANT VENTRICULAR TACHYARRHYTHMIAS", Journal of the American College of Cardiology, 29(2), 1997, pp. 14129-14129
25. REIFFEL JA
    PROLONGING SURVIVAL BY REDUCING ARRHYTHMIC DEATH - PHARMACOLOGICAL THERAPY OF VENTRICULAR-TACHYCARDIA AND FIBRILLATION
    The American journal of cardiology
    
    J.A. Reiffel, "PROLONGING SURVIVAL BY REDUCING ARRHYTHMIC DEATH - PHARMACOLOGICAL THERAPY OF VENTRICULAR-TACHYCARDIA AND FIBRILLATION", The American journal of cardiology, 80, 1997, pp. 45-55
26. CURTIS AB; HALLSTROM AP; KLEIN RC; NATH S; PINSKI SL; EPSTEIN AE; WYSE DG; CANNOM DS; RENFROE E; COOPER AS; DAILEY SM; KAY GN; PLUMB VJ; BUBIEN RS; KNOTTS SM; MCKENNA PT; GREER GS; SANTORO IH; SWAIM J; WHITTLE S; BELCO KM; PAYNE JP; ARNOLD DJ; ZHU WX; PRATT CM; COOK JR; KABELL G; KIRCHHOFFER JB; WARWICK D; BURKOTT B; TOMASZEWSKI D; PODRID PJ; FUCHS TT; MAZUR M; FRIEDMAN PL; STEVENSON WG; SWAT MM; GANZ LL; SWEENEY MO; SHEA JB; BRODSKY MA; ALLEN BJ; EHRLICH SS; WOLFF LJ; MACARIHINSON MM; SCHEINMAN M; EISENBERG S; EPSTEIN L; FITZPATRICK A; GRIFFIN G; LEE R; LESH M; WONG MN; WONG M; WILKOFF BL; CROSS JA; SHEWCHIK JM; CARLSON MD; ROSENBAUM DS; LEWIS WR; BIBLO LA; MACKALL JA; WALDO AL; COROMILAS J; BIGGER JT; LIVELLI FD; REIFFEL JA; HICKEY K; BERNS E; LIPPMAN N; BARRY MB; CARNEY HM; RUSSO AM; WAXMAN HL; STUBIN CA; MORRISSEY JM; RASPA DH; CHILSON DA; LESSMEIER TJ; POCHIS WT; BAXTER JM; NADEMANEE K; WEINBERGER J; BAILEY W; REITER M; SAKSENA S; KROL RB; MUNSIF AN; LEWIS CA; LUCERI RM; ZILO P; WEISS DN; JONAS A; VARDEMAN L; SCHWARTZ KM; CURTIS AB; CONTI JB; NELSON C; BHANDARI AK; LERMAN RD; FIRTH BR; ZIPES DP; ENGELSTEIN ED; MILES WM; FOREMAN L; MARTINS JB; LEE HC; HOPSON JR; HOPSON R; MARINCHAK RA; RIALS SJ; KOWEY PR; FILART RA; HERNANDEZ M; SCHER DL; ZUKERMAN LS; FARRELL S; KOLK D; CRINER H; TAIT B; KUTALEK SP; HESSEN SE; MOVSOWITZ C; SAMUELS F; WILBER S; BAESSLER C; SOTO D; SCHUSTER M; SCOTT G; COVELASKYROBINSON R; FLETCHER S; FINN LS; SAARI C; TORRES VI; PAL S; PLATT ML; TIMOTHY PCR; BISHOP VL; LOVE JC; CUTLER JE; BOSWORTHFARRELL S; GOLD MR; SHOROFSKY S; PETERS R; KAVESH N; FROMAN D; SCOTT H; ROTH JA; GADHOKE AM; MAUERMANN SK; PACIFICO A; NASIR N; TRAINOR K; FOSTER P; CREVEY B; GENOVELY H; SCHUTZMAN J; VIATER K; COYLE C; NORA MO; OTOOLE MF; COLLURA R; ENGER EL; ALMQUIST A; BALDWIN P; HAUSER R; MILSTEIN S; PRITZKER M; SCHREIBER V; KIM SG; FISHER JD; FERRICK KJ; GROSS JN; BENZUR U; DURKIN J; FERRICK A; ZEBEDE J; SAMET P; TOLENTINO AO; RUBIN S; HERRE JM; BERNSTEIN RC; KLEVAN LR; JADONATH RL; GOLDNER B; MERKATZ K; CHEPURKO L; BECKMAN KJ; MCCLELLAND JH; GONZALEZ MD; WIDMAN LE; LANE R; MCANULTY JH; HALPERIN BD; KRON J; LARSEN GC; RAITT MH; SWENSON RD; FLOREK RC; MARCHANT C; HAMLIN M; HEYWOOD G; DAUBERT JP; KIM C; SWITZER D; PANDE P; FLYNN D; KELLER M; OCAMPO CM; WAHL K; VOGT J; TULLO NG; IRMIERE CA; HENRY A; STEINBERG JS; EHLERT F; ZELENKOFSKE S; MENCHAVEZTAN E; DESTEFANO M; BROWN G; SUNG RJ; LIEM LB; YOUNG C; LAUER MR; PETERSON J; OTTOBONI L; GOOLD P; ROME M; KRESGE K; BUXTON AE; HSIA HH; MILLER JM; ROTHMAN SA; ADELIZZI N; GASTINEAU ME; THOME LM; WHITLEY DM; SHIH HT; DOUGHERTY AH; JALAL S; NACCARRELLI GV; WOLBRETTE D; WILSON D; PAGE RL; JESSEN M; CANBY RC; ERWIN G; ANDERSON JL; CRANDALL BG; KARAGOUNIS LA; OSBORN JS; RAWLING DA; SUMMERS K; BIGGINS M; FREEDMAN R; MARKS M; CHIEN W; STEVENOT R; MERILLAT J; MCPHERSON M; ECHT DS; RODEN DM; WATHEN MS; LEE JT; MURRAY KT; BAKER JH; CRAWFORD DM; HAINES D; ACKERMAN S; BOWMAN L; STAMATO NJ; WHITING D; JENKINS LS; CONNOLLY S; HALLSTROM AP; GREENE HL; YAO Q; SCHOLZ M; POWELL JL; RENFROE EG; SULLIVAN S; LEDINGHAM RB; MORRIS MF; LANCASTER SE; MOORE R; OLARTE A; SCHRON EB; DOMANSKI MJ; FOLLMANN D; ROSENBERG Y; JENNINGS CA
    INFLUENCE OF PATIENT CHARACTERISTICS IN THE SELECTION OF PATIENTS FORDEFIBRILLATOR IMPLANTATION (THE AVID REGISTRY)
    The American journal of cardiology
    
    A.B. Curtis et al., "INFLUENCE OF PATIENT CHARACTERISTICS IN THE SELECTION OF PATIENTS FORDEFIBRILLATOR IMPLANTATION (THE AVID REGISTRY)", The American journal of cardiology, 79(9), 1997, pp. 1185-1189
27. REIFFEL JA; HAHN E; HARTZ V; REITER MJ
    SOTALOL FOR VENTRICULAR TACHYARRHYTHMIAS - BETA-BLOCKING AND CLASS-III CONTRIBUTIONS, AND RELATIVE EFFICACY VERSUS CLASS-I DRUGS AFTER PRIOR DRUG FAILURE
    The American journal of cardiology
    
    J.A. Reiffel et al., "SOTALOL FOR VENTRICULAR TACHYARRHYTHMIAS - BETA-BLOCKING AND CLASS-III CONTRIBUTIONS, AND RELATIVE EFFICACY VERSUS CLASS-I DRUGS AFTER PRIOR DRUG FAILURE", The American journal of cardiology, 79(8), 1997, pp. 1048-1053
28. REITER MJ; KARAGOUNIS LA; MANN DE; REIFFEL JA; HAHN E; HARTZ V
    REPRODUCIBILITY OF DRUG EFFICACY PREDICTIONS BY HOLTER MONITORING IN THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING (ESVEM) TRIAL
    The American journal of cardiology
    
    M.J. Reiter et al., "REPRODUCIBILITY OF DRUG EFFICACY PREDICTIONS BY HOLTER MONITORING IN THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING (ESVEM) TRIAL", The American journal of cardiology, 79(3), 1997, pp. 315-322
29. MASON JW; MARCUS FI; BIGGER JT; LAZZARA R; REIFFEL JA; REITER MJ; MANN D
    A SUMMARY AND ASSESSMENT OF THE FINDINGS AND CONCLUSIONS OF THE ESVEMTRIAL
    Progress in cardiovascular diseases
    
    J.W. Mason et al., "A SUMMARY AND ASSESSMENT OF THE FINDINGS AND CONCLUSIONS OF THE ESVEMTRIAL", Progress in cardiovascular diseases, 38(5), 1996, pp. 347-358
30. REIFFEL JA; REITER MJ; FREEDMAN RA; MANN D; HUANG SKS; HAHN E; HARTZ V; MASON J; MARCUS FI; CARUSO A; FAITELSON HL; RAYA TE; GARCIA Z; GEAR K; PIERCE MK; PRATT CM; BOAHENE A; PACIFICO A; WYNDHAM C; FRANCIS M; KERR CR; YEUNG JA; VORDERBRUGGE S; GRIFFIN JC; LESH M; SCHEINMAN MM; WONG M; WONG M; HEYBORNE T; KENNY C; BIGGER JT; LIVELLI FD; STEINBERG JS; CAMPION J; SQUATRITO AM; MITTLEMAN R; COLLETTWILLEY P; ROFINO K; SAKSENA S; KROL RB; DUQUE L; KLEIN RC; MACHELL C; WIDMAN ML; ACOSTAMILLER C; LOMELI G; KEHOE R; ZHEUTLIN TA; MATTIONI T; DUNNINGTON C; LAZZARA R; BECKMAN K; FRIDAY K; JACKMAN WM; DEATON T; DRENNAN K; FOSTER J; HARRIS S; MCANULTY JH; KRON J; HALPERIN BD; SINNER K; MARTIN K; HOROWITZ LN; GOTTLIEB CD; VRABEL C; MASON JW; ANDERSON JL; ANDERSON KP; KARAGOUNIS L; RAWLING DA; HUTSON H; MANNIS D; ROSKELLEY M; MOON T; RICO A; JENROW N; BRESSLER R; GREENE HL; LEBOWITZ M; MORKIN E; WEAVER WD; BUMP T; MORADY F; OLSHANSKY B
    INFLUENCE OF HOLTER MONITOR AND ELECTROPHYSIOLOGIC STUDY METHODS AND EFFICACY CRITERIA ON THE OUTCOME OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION IN THE ESVEM TRIAL
    Progress in cardiovascular diseases
    
    J.A. Reiffel et al., "INFLUENCE OF HOLTER MONITOR AND ELECTROPHYSIOLOGIC STUDY METHODS AND EFFICACY CRITERIA ON THE OUTCOME OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION IN THE ESVEM TRIAL", Progress in cardiovascular diseases, 38(5), 1996, pp. 359-370
31. PRATT CM; GREENWAY PS; SCHOENFELD MH; HIBBEN ML; REIFFEL JA
    EXPLORATION OF THE PRECISION OF CLASSIFYING SUDDEN CARDIAC DEATH - IMPLICATIONS FOR THE INTERPRETATION OF CLINICAL-TRIALS
    Circulation
    
    C.M. Pratt et al., "EXPLORATION OF THE PRECISION OF CLASSIFYING SUDDEN CARDIAC DEATH - IMPLICATIONS FOR THE INTERPRETATION OF CLINICAL-TRIALS", Circulation, 93(3), 1996, pp. 519-524
32. REIFFEL JA
    IMPLICATIONS OF THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING TRIAL FOR CONTROLLING VENTRICULAR-TACHYCARDIA AND FIBRILLATION
    The American journal of cardiology
    
    J.A. Reiffel, "IMPLICATIONS OF THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING TRIAL FOR CONTROLLING VENTRICULAR-TACHYCARDIA AND FIBRILLATION", The American journal of cardiology, 78, 1996, pp. 34-40
33. REIFFEL JA; BANKER J
    HOW DO PHYSICIANS DETERMINE WHEN TO PERFORM AN ON-DRUG ELECTROPHYSIOLOGY STUDY FOR EFFICACY DETERMINATION IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS - A PREVIOUSLY UNADDRESSED VARIABLE THAT MAY AFFECT EFFICACY RATES
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    J.A. Reiffel e J. Banker, "HOW DO PHYSICIANS DETERMINE WHEN TO PERFORM AN ON-DRUG ELECTROPHYSIOLOGY STUDY FOR EFFICACY DETERMINATION IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS - A PREVIOUSLY UNADDRESSED VARIABLE THAT MAY AFFECT EFFICACY RATES", PACE, 18(3), 1995, pp. 406-416
34. EPSTEIN AE; CONTI JB; CURTIS AB; HESS PG; IANSMITH DH; LOTT JW; MULHOLLAND DH; BUBIEN RS; HAMILTON B; KNOTTS SM; MARDIS M; VINCENT LA; FRIEDMAN PL; STEVENSON W; MARLIN R; SHEA JB; SCHEINMAN M; EISENBERG S; EPSTEIN L; FITZPATRICK A; GRIFFIN G; LEE R; LESH M; WONG MN; WONG M; WILKOFF BL; PINSKI SL; CROSS JA; SCHEWCHIK J; BIGGER JT; COROMILAS J; LIVELLI FD; REIFFEL JA; HICKEY K; NADEMANEE K; WEINBERGER J; BAILEY W; BLANKENSHIP M; SAKSENA S; LEWIS C; WENDLER I; CANNOM D; BHANDARI AK; LERMAN RD; FIRTH BR; ZIPES D; MITRANI R; MILES W; KLEIN L; MARINCHAK R; SCHER DL; ZUKERMAN S; FALCO K; FARRELL S; FISHER B; BRIGGS B; CHIKOWSKI M; CRINER H; KUTALEK S; BAESSLER C; SOTO D; TORRES V; PAI S; TIMOTHY P; BISHOP V; PACIFICO A; NASIR N; RODRIGUEZ I; CALI D; KIM SG; FISHER JD; FERRICK KJ; ROTH JA; GROSS J; MAGNANI M; DURKIN J; FERRICK A; GOMES JA; NELSON S; BECKMAN KJ; LANE R; MCCLELLAND JH; STRAUGHN NG; FOSTER JL; MCANULTY J; FLOREK RC; HALPERIN BD; KRON J; LARSEN GC; SWENSON RD; MARCHANT C; AKIYAMA T; DAUBERT JP; PANDE P; SWITZER D; FLYNN D; OCAMPO C; VOGT J; WAHL K; HERRE JM; LINETTE R; KLEVAN LR; BARACKMAN K; RAYMOND L; SUNG R; LAUER M; LIEM LB; YOUNG C; PETERSON J; OTTOBONI L; STEINBERG J; ZELENKOFSKE S; EHLERT F; TAN EM; WINAND M; CLEVELAND L; BUXTON AE; ADELIZZI N; STEIN D; NACCARRELLI G; DOUGHERTY A; JALAL S; MALONEY J; RIZOPATRON C; SHIH T; ZHU DWX; WILSON D; BELCO K; BERRIER H; POVIA C; ANDERSON JL; CRANDALL BG; KARAGOUNIS LA; OSBORN JS; RAWLING DA; SUMMERS K; BIGGINS M; ECHT D; RODEN D; LEE JT; MURRAY K; WATHEN M; BAKER J; CRAWFORD D; KUDENCHUK P
    ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) - RATIONALE,DESIGN, AND METHODS
    The American journal of cardiology
    
    A.E. Epstein et al., "ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) - RATIONALE,DESIGN, AND METHODS", The American journal of cardiology, 75(7), 1995, pp. 470-475
35. LIPKA LJ; DIZON JM; REIFFEL JA
    DESIRED MECHANISMS OF DRUGS FOR VENTRICULAR ARRHYTHMIA - CLASS-III ANTIARRHYTHMIC AGENTS
    The American heart journal
    
    L.J. Lipka et al., "DESIRED MECHANISMS OF DRUGS FOR VENTRICULAR ARRHYTHMIA - CLASS-III ANTIARRHYTHMIC AGENTS", The American heart journal, 130(3), 1995, pp. 632-640
36. REIFFEL JA; ESTES NAM; WALDO AL; PRYSTOWSKY EN; DIBIANCO R
    A CONSENSUS REPORT ON ANTIARRHYTHMIC DRUG-USE
    Clinical cardiology
    
    J.A. Reiffel et al., "A CONSENSUS REPORT ON ANTIARRHYTHMIC DRUG-USE", Clinical cardiology, 17(3), 1994, pp. 103-116
37. REIFFEL JA; KUEHNERT MJ
    ELECTROPHYSIOLOGICAL TESTING OF SINUS NODE FUNCTION - DIAGNOSTIC AND PROGNOSTIC APPLICATION - INCLUDING UPDATED INFORMATION FROM SINUS NODEELECTROGRAMS
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    J.A. Reiffel e M.J. Kuehnert, "ELECTROPHYSIOLOGICAL TESTING OF SINUS NODE FUNCTION - DIAGNOSTIC AND PROGNOSTIC APPLICATION - INCLUDING UPDATED INFORMATION FROM SINUS NODEELECTROGRAMS", PACE, 17(3), 1994, pp. 349-365
38. REIFFEL JA; CORREIA J
    IN THE ABSENCE OF STRUCTURAL HEART-DISEASE .... - WHAT IS IT, AND WHYDOES IT MATTER IN ANTIARRHYTHMIC DRUG-THERAPY
    The American heart journal
    
    J.A. Reiffel e J. Correia, "IN THE ABSENCE OF STRUCTURAL HEART-DISEASE .... - WHAT IS IT, AND WHYDOES IT MATTER IN ANTIARRHYTHMIC DRUG-THERAPY", The American heart journal, 128(3), 1994, pp. 626-629